Nitroxyl (HNO) as a vasoprotective signaling molecule

Bullen, M. L., Miller, A. A. , Andrews, K. L., Irvine, J. C., Ritchie, R. H., Sobey, C. G. and Kemp-Harper, B. K. (2011) Nitroxyl (HNO) as a vasoprotective signaling molecule. Antioxidants and Redox Signaling, 14(9), pp. 1675-1686. (doi: 10.1089/ars.2010.3327) (PMID:2067312)

Full text not currently available from Enlighten.

Abstract

Nitroxyl (HNO), the one electron reduced and protonated form of nitric oxide (NO•), is rapidly emerging as a novel nitrogen oxide with distinct pharmacology and therapeutic advantages over its redox sibling. Whilst the cardioprotective effects of HNO in heart failure have been established, it is apparent that HNO may also confer a number of vasoprotective properties. Like NO•, HNO induces vasodilatation, inhibits platelet aggregation, and limits vascular smooth muscle cell proliferation. In addition, HNO can be putatively generated within the vasculature, and recent evidence suggests it also serves as an endothelium-derived relaxing factor (EDRF). Significantly, HNO targets signaling pathways distinct from NO• with an ability to activate KV and KATP channels in resistance arteries, cause coronary vasodilatation in part via release of calcitonin-gene related peptide (CGRP), and exhibits resistance to scavenging by superoxide and vascular tolerance development. As such, HNO synthesis and bioavailability may be preserved and/or enhanced during disease states, in particular those associated with oxidative stress. Moreover, it may compensate, in part, for a loss of NO• signaling. Here we explore the vasoprotective actions of HNO and discuss the therapeutic potential of HNO donors in the treatment of vascular dysfunction.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Miller, Dr Alyson
Authors: Bullen, M. L., Miller, A. A., Andrews, K. L., Irvine, J. C., Ritchie, R. H., Sobey, C. G., and Kemp-Harper, B. K.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:Antioxidants and Redox Signaling
Publisher:Mary Ann Liebert
ISSN:1523-0864
ISSN (Online):1557-7716
Published Online:02 November 2010

University Staff: Request a correction | Enlighten Editors: Update this record